Form 6-K Alpha Tau Medical Ltd. For: Aug 10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-41316
Alpha Tau Medical Ltd.
(Exact Name of Registrant as Specified in Its Charter)
Kiryat HaMada St. 5
Jerusalem, Israel 9777605
+972 (3) 577-4115
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
On August 10, 2026, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE).” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.
This Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-264306, 333-274457, 333-288240 and 333-295359) and Form S-8 (File Nos. 333-264169, 333-270406, 333-277733, 333-285745 and 333-294151).
1
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press release dated August 10, 2026. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Alpha Tau Medical Ltd. | ||
| Date: August 10, 2026 | By: | /s/ Uzi Sofer |
| Uzi Sofer | ||
| Chief Executive Officer | ||
3
ATTACHMENTS / EXHIBITS